Growth Metrics

Gyre Therapeutics (GYRE) Non-Current Assets (2016 - 2025)

Gyre Therapeutics (GYRE) has disclosed Non-Current Assets for 16 consecutive years, with $63.8 million as the latest value for Q4 2025.

  • Quarterly Non-Current Assets rose 5.18% to $63.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $247.3 million through Dec 2025, down 4.06% year-over-year, with the annual reading at $63.8 million for FY2025, 5.18% up from the prior year.
  • Non-Current Assets for Q4 2025 was $63.8 million at Gyre Therapeutics, up from $60.8 million in the prior quarter.
  • The five-year high for Non-Current Assets was $70.4 million in Q3 2024, with the low at $773000.0 in Q3 2022.
  • Average Non-Current Assets over 5 years is $31.8 million, with a median of $20.0 million recorded in 2021.
  • The sharpest move saw Non-Current Assets crashed 83.1% in 2022, then surged 1357.6% in 2024.
  • Over 5 years, Non-Current Assets stood at $4.2 million in 2021, then skyrocketed by 738.51% to $35.1 million in 2022, then soared by 69.0% to $59.3 million in 2023, then grew by 2.19% to $60.6 million in 2024, then grew by 5.18% to $63.8 million in 2025.
  • According to Business Quant data, Non-Current Assets over the past three periods came in at $63.8 million, $60.8 million, and $61.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.